Peripheral blood mono-nuclear cells derived from Alzheimer's disease patients show elevated baseline levels of secreted cytokines but resist stimulation with β-amyloid peptide

Molecular and Cellular Neuroscience

Volumn 49, Issue 1, 2012, Pages 77-84

  Rocha, Natália Pessoa ^a   Teixeira, Antônio Lúcio ^a   Coelho, Fernanda Matos ^a   Caramelli, Paulo ^a   Guimarães, Henrique Cerqueira ^a   Barbosa, Izabela Guimarães ^a   da Silva, Tarcilia Aparecida ^a   Mukhamedyarov, Marat Alexandrovich ^b   Zefirov, Andrey Lvovich ^b   Rizvanov, Albert Anatolyevich ^b,c,d,e   Kiyasov, Andrey Pavlovich ^b,e   Vieira, Luciene B ^a   Janka, Zoltán ^f   Palotás, András ^g   Reis, Helton José ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^c KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^d YEDITEPE UNIVERSITY   (Turkey)

^e Republic Clinical Hospital   (Russian Federation)

^f UNIVERSITY OF SZEGED   (Hungary)

^g Asklepios Med (private medical practice and research center)   (Hungary)

Author keywords

amyloid peptide; Aging; Alzheimer's disease; Cytokine; Inflammaging; Peripheral blood mono nuclear cell (PBMC)

Indexed keywords

AMYLOID BETA PROTEIN; CD28 ANTIBODY; CD3 ANTIBODY; CELL ANTIBODY; CYTOKINE; INTERLEUKIN 1BETA; UNCLASSIFIED DRUG;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEUKOCYTE; MALE; OBSERVATIONAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED;

EID: 84155166859     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2011.09.005     Document Type: Article

References (58)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
2. Alzheimer's Association Alzheimer's disease facts and figures. Alzheimers Dement. 2009, 5:234-270.
3. Bertolucci P.H., Brucki S.M., Campacci S.R., Juliano Y. The Mini-Mental State Examination in a general population: impact of educational status. Arq. Neuropsiquiatr. 1994, 52:1-7.
4. Brod S.A. Unregulated inflammation shortens human functional longevity. Inflamm. Res. 2000, 49:561-570.
5. Bruunsgaard H., Andersen-Ranberg K., Hjelmborg J.B., Pedersen B.K., Jeune B. Elevated levels of tumor necrosis factor-α and mortality in centenarians. Am. J. Med. 2003, 115:278-283.
6. Cochran E., Bacci B., Chen Y., Patton A., Gambetti P., Autilio-Gambetti L. Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease. Am. J. Pathol. 1991, 139:485-489.
7. Connolly G.P. Fibroblast models of neurological disorders: fluorescence measurement studies. Trends Pharmacol. Sci. 1998, 19:171-177.
8. de Jong F.J., Masaki K., Chen H., Remaley A.T., Breteler M.M., Petrovitch H., White L.R., Launer L.J. Thyroid function, the risk of dementia and neuropathologic changes: the Honolulu-Asia aging study. Neurobiol. Aging 2009, 30:600-606.
9. Diniz B.S., Teixeira A.L., Talib L., Gattaz W.F., Forlenza O.V. Interleukin-1β serum level is increased in antidepressant-free elderly depressed patients. Am. J. Geriatr. Psychiatry 2010, 18:172-176.
10. Dolman C.L. Diagnosis of neurometabolic disorders by examination of skin biopsies and lymphocytes. Semin. Diagn. Pathol. 1984, 1:82-97.
11. Drzyzga L., Obuchowicz E., Marcinowska A., Herman Z.S. Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav. Immun. 2006, 20:532-545.
12. Dubois B., Feldman H.H., Jacova C., de Kosky S.T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007, 6:734-746.
13. Einstein G., Buranosky R., Crain B.J. Dendritic pathology of granule cells in Alzheimer's disease is unrelated to neuritic plaques. J. Neurosci. 1994, 14:5077-5088.
14. Ershler W.B., Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med. 2000, 51:245-270.
15. Etminan M., Gill S., Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ 2003, 327:128-131.
16. Evans D.A., Hebert L.E., Beckett L.A., Scherr P.A., Albert M.S., Chown M.J., Pilgrim D.M., Taylor J.O. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch. Neurol. 1997, 54:1399-1405.
17. Fuss I.J., Kanof M.E., Smith P.D., Zola H. Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr. Protoc. Immunol. 2009, (chapter 7: unit 7.1).
18. Gearing M., Wilson R.W., Unger E.R., Shelton E.R., Chan H.W., Masters C.L., Beyreuther K., Mirra S.S. Amyloid precursor protein (APP) in the striatum in Alzheimer's disease: an immunohistochemical study. J. Neuropathol. Exp. Neurol. 1993, 52:22-30.
19. Gerli R., Monti D., Bistoni O., Mazzone A.M., Peri G., Cossarizza A., DiGioacchino M., Cesarotti M.E., Doni A., Mantovani A., Franceschi C., Paganelli R. Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mech. Ageing Dev. 2000, 121:37-46.
20. Giunta B., Fernandez F., Nikolic W.V., Obregon D., Rrapo E., Town T., Tan J. Inflammaging as a prodrome to Alzheimer's disease. J. Neuroinflamm. 2008, 5:51.
21. Griffin W.S.T., Mrak R.E. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J. Leukoc. Biol. 2002, 72:233-238.
22. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
23. Harris, T., Carey, I.M., Shah, S.M., Dewilde, S., Cook, D.G., in press. Antidepressant prescribing in older primary care patients in community and care home settings in England and Wales. J. Am. Med. Dir. Assoc.
24. Heneka M.T., O'Banion M.K. Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 2007, 184:69-91.
25. Hoffmann S.C., Stanley E.M., Cox E.D., Craighead N., DiMercurio B.S., Koziol D.E., Harlan D.M., Kirk A.D., Blair P.J. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 2001, 72:1444-1450.
26. Huang H.M., Martins R., Gandy S., Etcheberrigaray R., Ito E., Alkon D.L., Blass J.P., Gibson G.E. The use of cultured fibroblasts in elucidating the pathophysiology and diagnosis of Alzheimer's disease. Calcium Hypothesis of Aging and Dementia 1994, 225-244. New York Academy of Science, New York. J.F. Disterhoft, W.H. Gispen, J. Traber, Z.S. Khachaturian (Eds.).
27. Hunt K.J., Walsh B.M., Voegeli D., Roberts H.C. Inflammation in aging, part 1: physiology and immunological mechanisms. Biol. Res. Nurs. 2010, 11:245-252.
28. Idoate-Gastearena M.A., Vega-Vazquez F. Diagnosis of neurometabolic and neurodegenerative diseases by cutaneous biopsy. Rev. Neurol. 1997, 25:S269-S280.
29. Joachim C.L., Mori H., Selkoe D.J. Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease. Nature (Lond) 1989, 341:226-230.
30. Kenis G., Maes M. Effects of antidepressants on the production of cytokines. Int. J. Neuropsychopharmacol. 2002, 5:401-412.
31. Leonard B.E. Inflammation, depression and dementia: are they connected?. Neurochem. Res. 2007, 32:1749-1756.
32. Lue L.F., Rydel R., Brigham E.F., Yang L.B., Hampel H., Murphy G.M., Brachova L., Yan S.D., Walker D.G., Shen Y., Rogers J. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 2001, 35:72-79.
33. Mackenzie I.R., Munoz D.G. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 1998, 50:986-990.
34. (25-35) induces the production of interleukin-8 from human monocytes. J. Neuroimmunol. 1995, 59:29-33.
35. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
36. Milea D., Verpillat P., Guelfucci F., Toumi M., Lamure M. Prescription patterns of antidepressants: findings from a US claims database. Curr. Med. Res. Opin. 2010, 26(6):1343-1353.
37. O'Mahony L., Holland J., Jackson J., Feighery C., Hennessy T.P., Mealy K. Quantitative intracellular cytokine measurement: age-related changes in proinflammatory cytokine production. Clin. Exp. Immunol. 1998, 113:213-219.
38. Palotás A., Kálmán J. Candidate susceptibility genes in Alzheimer's disease are at high risk for being forgotten - they don't give peace of mind. Curr. Drug Metab. 2006, 7(3):273-293.
39. i-level of fibroblasts from Alzheimer patients and control individuals. Neurochem. Res. 2001, 26(7):817-820.
40. Palotás A., Kálmán J., Palotás M., Juhász A., Janka Z., Penke B. β-amyloid-induced increase in the resting intracellular calcium concentration gives support to tell Alzheimer lymphocytes from control ones. Brain Res. Bull. 2002, 58(2):203-205.
41. Palotás A., Kálmán J., Palotás M., Kemény L., Janka Z., Penke B. Long-term exposition of cells to β-amyloid results in decreased intracellular calcium concentration. Neurochem. Int. 2003, 42(7):543-547.
42. Popko K., Gorska E., Stelmaszczyk-Emmel A., Plywaczewski R., Stoklosa A., Gorecka D., Pyrzak B., Demkow U. Proinflammatory cytokines IL-6 and TNF-α and the development of inflammation in obese subjects. Eur. J. Med. Res. 2010, 15(Suppl. 2):120-122.
43. Reis H.J., Mukhamedyarov M.A., Rizvanov A.A., Palotás A. A new story about an old guy: is Alzheimer's disease infectious?. Neurodegener. Dis. 2010, 7(4):272-278.
44. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
45. Scalzo P., Kümmer A., Cardoso F., Teixeira A.L. Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease. J. Neuroimmunol. 2009, 216:122-125.
46. Schmidt J., Barthel K., Wrede A., Salajegheh M., Bähr M., Dalakas M.C. Interrelation of inflammation and APP in sIBM: IL-1β induces accumulation of β-amyloid in skeletal muscle. Brain 2008, 131:1228-1240.
47. Schwarz M.J., Chiang S., Müller N., Ackenheil M. T-helper-1 and T-helper-2 responses in psychiatric disorders. Brain Behav. Immun. 2001, 15:340-370.
48. Stewart W.F., Kawas C., Corrada M., Metter E.J. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997, 48:626-632.
49. Székely C.A., Thorne J.E., Zandi P.P., Ek M., Messias E., Breitner J.C., Goodman S.N. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 2004, 23:159-169.
50. Tan J., Town T., Paris D., Mori T., Suo Z., Crawford F., Mattson M.P., Flavell R.A., Mullan M. Microglial activation resulting from CD40-CD40L interaction after β-amyloid stimulation. Science (Wash DC) 1999, 286:2352-2355.
51. Tan Z.S., Beiser A., Vasan R.S., Au R., Auerbach S., Kiel D.P., Wolf P.A., Seshadri S. Thyroid function and the risk of Alzheimer disease: the Framingham Study. Arch. Intern. Med. 2008, 168:1514-1520.
52. Tarazona R., Solana R., Ouyang Q., Pawaelec G. Basic biology and clinical impact of immunosenescence. Exp. Gerontol. 2002, 37:183-189.
53. Tarkowski E., Andreasen N., Tarkowski A., Blennow K. Intrathecal inflammation precedes development of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2003, 74:1200-1205.
54. Teixeira A.L., Reis H.J., Coelho F.M., Carneiro D.S., Teixeira M.M., Vieira L.B., Mukhamedyarov M.A., Zefirov A.L., Janka Z., Palotás A. All-or-nothing type biphasic cytokine production of human lymphocytes after exposure to Alzheimer's β-amyloid peptide. Biol. Psychiatry 2008, 64(10):891-895.
55. Terry R.D. Alzheimer's disease and the aging brain. J. Geriatr. Psychiatry Neurol. 2006, 19(3):125-128.
56. Weiskopf D., Weinberger B., Grubeck-Loebenstein B. The aging of the immune system. Transpl. Int. 2009, 22:1041-1050.
57. Weisman D., Hakimian E., Ho G.J. Interleukins, inflammation, and mechanisms of Alzheimer's disease. Vitam. Horm. 2006, 74:505-530.
58. Xue S.R., Xu D.H., Yang X.X., Dong W.L. Alterations in lymphocyte subset patterns and co-stimulatory molecules in patients with Alzheimer disease. Chin. Med. J. (Engl.) 2009, 122:1469-1472.